M&A Deal Summary

Zoetis Acquires Jurox

On August 4, 2021, Zoetis acquired consumer products company Jurox

Acquisition Highlights
  • This is Zoetis’ 1st transaction in the Consumer Products sector.
  • This is Zoetis’ 2nd transaction in Australia.

M&A Deal Summary

Date 2021-08-04
Target Jurox
Sector Consumer Products
Buyer(s) Zoetis
Deal Type Add-on Acquisition

Target

Jurox

Rutherford, Australia
Jurox is a privately held animal health company, which develops, manufactures, and markets a wide range of veterinary medicines for treating companion animals and livestock. Jurox’s operations are based in Australia, with additional regional offices and subsidiaries in New Zealand, U.S., Canada, and the UK. Jurox is based in Rutherford, Australia.

Search 204,883 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Zoetis

Parsippany, New Jersey, United States

Category Company
Founded 1952
Sector Life Science
Employees11,300
Revenue 8.5B USD (2023)
DESCRIPTION

Zoetis engages in the discovery, development, manufacture and commercialization of a diverse portfolio of animal health medicines and vaccines designed to meet the real-world needs of veterinarians and the livestock farmers and companion animal owners they support. Zoetis was founded in 1952 and is based in Parsippany, New Jersey.


DEAL STATS #
Overall 12 of 13
Sector (Consumer Products) 1 of 1
Type (Add-on Acquisition) 11 of 12
Country (Australia) 2 of 2
Year (2021) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2020-02-07 Ethos Diagnostic Science

San Diego, California, United States

Ethos Diagnostic Science is a full-service veterinary diagnostic laboratory founded in 2015 as the former STAT Veterinary Lab. With lab locations in Boston, Denver and San Diego, Ethos Diagnostic Science performs testing for all veterinary species in hematology, clinical chemistry, urinalysis, microbiology, parasitology, endocrinology, serology, cytology and histology, and aims to provide the highest quality results and rapid turnaround times, while advancing the field of veterinary diagnostic medicine.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2022-06-07 Basepaws

Torrance, California, United States

Basepaws is a petcare genetics company that builds early detection health risk tests based on genetic and microbiome data. The company is committed to companion animal health research, and it has the world’s first at-home genetic testing platform for cats. Basepaws was founded in 2017 and is based in Torrance, California.

Buy $50M